Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
暂无分享,去创建一个
[1] R. Leigh,et al. Tremor of the Eyes, or of the Head, in Parkinson's Disease? , 2013, Movement disorders : official journal of the Movement Disorder Society.
[2] A. Lees,et al. Visual dysfunction in Parkinson’s disease , 2016, Brain : a journal of neurology.
[3] Y. J. Liao,et al. Abnormal eye movement behavior during reading in Parkinson's disease. , 2016, Parkinsonism & related disorders.
[4] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[5] O. Levy,et al. The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[6] K. Fukushima,et al. Clinical application of eye movement tasks as an aid to understanding Parkinson’s disease pathophysiology , 2017, Experimental Brain Research.
[7] B. Gaymard. Cortical and sub-cortical control of saccades and clinical application. , 2012, Revue neurologique.
[8] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[9] O. Hikosaka,et al. New perspectives on the pathophysiology of Parkinson’s disease as assessed by saccade performance: A clinical review , 2013, Clinical Neurophysiology.
[10] Philip L De Jager,et al. Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.
[11] P. Calabresi,et al. Direct and indirect pathways of basal ganglia: a critical reappraisal , 2014, Nature Neuroscience.
[12] J. Deakin,et al. Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease. , 2002, Progress in brain research.
[13] M G Saslow,et al. Latency for saccadic eye movement. , 1967, Journal of the Optical Society of America.
[14] T. Mergner,et al. What is pathological with gaze shift fragmentation in Parkinson's disease? , 2002, Journal of Neurology.
[15] F. Binkofski,et al. Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations , 2010, Movement disorders : official journal of the Movement Disorder Society.
[16] D. Kömpf,et al. Different saccadic abnormalities in PINK1 mutation carriers and in patients with non-genetic Parkinson’s disease , 2009, Journal of Neurology.
[17] Tim Anderson,et al. Don’t look now or look away: Two sources of saccadic disinhibition in Parkinson's disease? , 2008, Neuropsychologia.
[18] J. Sweeney,et al. Pharmacological treatment effects on eye movement control , 2008, Brain and Cognition.
[19] M. Koenig,et al. Ophthalmic features of PLA2G6-related paediatric neurodegeneration with brain iron accumulation , 2014, British Journal of Ophthalmology.
[20] R. Schiffmann,et al. The Saccadic and Neurological Deficits in Type 3 Gaucher Disease , 2011, PloS one.
[21] S. Lindquist,et al. α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity , 2009, Nature Genetics.
[22] G. Mankekar,et al. Clinical Features and Diagnosis , 2014 .
[23] M. Repka,et al. Ocular motor and sensory function in Parkinson's disease. , 2012, Ophthalmology.
[24] C Kennard,et al. Oculomotor abnormalities in diseases of the basal ganglia. , 1989, Revue neurologique.
[25] K. Marder,et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.
[26] A. Lees,et al. Kufor Rakeb Disease: Autosomal recessive, levodopa‐responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.
[27] P. May. The mammalian superior colliculus: laminar structure and connections. , 2006, Progress in brain research.
[28] Thomas Wichmann,et al. Update on models of basal ganglia function and dysfunction. , 2009, Parkinsonism & related disorders.
[29] Douglas C. Miller,et al. A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.
[30] Paul A Wetzel,et al. Pervasive ocular tremor in patients with Parkinson disease. , 2012, Archives of neurology.
[31] Richard D. Jones,et al. Adaptive modification of saccade amplitude in Parkinson's disease. , 2002, Brain : a journal of neurology.
[32] H. Shibasaki,et al. Oculomotor abnormalities in Parkinson's disease. , 1979, Archives of neurology.
[33] B. Oostra,et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. , 2012, American journal of human genetics.
[34] O. Hikosaka. Basal Ganglia Mechanisms of Reward‐Oriented Eye Movement , 2007, Annals of the New York Academy of Sciences.
[35] D. Munoz,et al. Probing basal ganglia functions by saccade eye movements , 2011, The European journal of neuroscience.
[36] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[37] W. Heide,et al. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD , 2010, Neurology.
[38] A Beuter,et al. Fluctuations in tremor at rest and eye movements during ocular fixation in subjects with Parkinson's disease. , 1998, Parkinsonism & related disorders.
[39] C. Harris,et al. Ocular motor abnormalities in Gaucher disease. , 1999, Neuropediatrics.
[40] A. Srivastava,et al. Saccadic eye movements in Parkinson's disease , 2014, Indian journal of ophthalmology.
[41] Jan Kassubek,et al. Alterations of Eye Movement Control in Neurodegenerative Movement Disorders , 2014, Journal of ophthalmology.
[42] Soma Das,et al. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). , 2005, American journal of ophthalmology.
[43] Elias Provencio-Vasquez,et al. A decade in review , 2010 .
[44] R. Hanajima,et al. Small saccades restrict visual scanning area in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[45] K. Marder,et al. Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.
[46] Thomas Wichmann,et al. Circuits and circuit disorders of the basal ganglia. , 2007, Archives of neurology.
[47] C. Helmchen,et al. Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations , 2006, Journal of Neurology.
[48] Wei Zheng,et al. Manganese Toxicity Upon Overexposure: a Decade in Review , 2015, Current Environmental Health Reports.
[49] L. Optican,et al. Eye movements in genetic parkinsonisms affecting the α-synuclein, PARK9, and manganese network , 2017, Clinical Neurophysiology.
[50] Antisaccades in Parkinson disease , 2017, Neurology.
[51] E. Bézard,et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.
[52] A. Sprenger,et al. Eye movement disorders in ATP13A2 mutation carriers (PARK9) , 2010, Movement disorders : official journal of the Movement Disorder Society.
[53] C. Kennard,et al. Antisaccades and executive dysfunction in early drug‐naive Parkinson's disease: The discovery study , 2015, Movement disorders : official journal of the Movement Disorder Society.
[54] R. Tomlinson,et al. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. , 1983, Brain : a journal of neurology.
[55] D. Buckwell,et al. Ocular Tremor in Parkinson's Disease Is Due to Head Oscillation , 2013, Movement disorders : official journal of the Movement Disorder Society.
[56] L. Optican,et al. Mechanism of interrupted saccades in patients with late-onset Tay-Sachs disease. , 2008, Progress in brain research.
[57] Ocular tremor in Parkinson's disease: The debate is not over , 2013, Movement disorders : official journal of the Movement Disorder Society.
[58] M. Saslow. Effects of components of displacement-step stimuli upon latency for saccadic eye movement. , 1967, Journal of the Optical Society of America.
[59] Julie M. Hall,et al. Antisaccade errors reveal cognitive control deficits in Parkinson’s disease with freezing of gait , 2015, Journal of Neurology.
[60] Brian E. Keck. A Critical Reappraisal , 2010 .
[61] T. Anderson,et al. Eye movements in patients with neurodegenerative disorders , 2013, Nature Reviews Neurology.
[62] O. Hikosaka,et al. Role of the basal ganglia in the control of purposive saccadic eye movements. , 2000, Physiological reviews.
[63] B. Gaymard,et al. Eye Movements in Ephedrone-Induced Parkinsonism , 2014, PloS one.
[64] A. Beuter,et al. Fluctuations in tremor at rest and saccadic eye movements in subjects with Parkinsons disease. , 1997, Parkinsonism & related disorders.
[65] M. Castelo‐Branco,et al. Distinct functional properties of the vertical and horizontal saccadic network in Health and Parkinson's disease: An eye-tracking and fMRI study , 2016, Brain Research.
[66] M. Hallett,et al. The cerebellum in Parkinson’s disease , 2013, Brain : a journal of neurology.
[67] D. Zee,et al. ‘Staircase’ square-wave jerks in early Parkinson's disease , 2010, British Journal of Ophthalmology.
[68] J. Gnadt,et al. Activity of omnipause neurons during “staircase saccades” elicited by persistent microstimulation of the superior colliculus , 2006, Vision Research.
[69] P. Alfonso,et al. Neurological evaluation of patients with Gaucher disease diagnosed as type 1 , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[70] M Vidailhet,et al. Mixing pro- and antisaccades in patients with parkinsonian syndromes. , 2006, Brain : a journal of neurology.
[71] G. Fraedrich,et al. Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.
[72] Tatiana Foroud,et al. Multiple step pattern as a biomarker in Parkinson disease. , 2009, Parkinsonism & related disorders.
[73] Masaya Segawa,et al. Initiation and inhibitory control of saccades with the progression of Parkinson's disease – Changes in three major drives converging on the superior colliculus , 2011, Neuropsychologia.
[74] R. Armstrong,et al. Oculo-Visual Dysfunction in Parkinson’s Disease , 2015, Journal of Parkinson's disease.